导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 97.54% | 3/1050 |
| 近一周 | 2.48% | 82/1104 |
| 近一月 | 1.39% | 50/1103 |
| 近一季 | 4.64% | 150/1092 |
| 近半年 | 78.42% | 3/1070 |
| 近一年 | 126.07% | 1/1018 |
| 近两年 | 340.04% | 7/926 |
| 近三年 | 296.46% | 5/834 |
| 成立以来 | 520.21% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
5.48% 125/1070 |
123.28% 9/1101 |
- - |
- - |
| 2025 | 84.80% 31/1065 |
6.77% 300/1014 |
1.00% 613/1038 |
68.19% 14/1050 |
1.89% 317/1065 |
| 2024 | 14.90% 175/1011 |
2.42% 193/960 |
-0.91% 371/983 |
12.18% 444/991 |
0.92% 276/1011 |
| 2023 | -13.96% 477/952 |
7.64% 186/880 |
-0.92% 236/895 |
-14.32% 755/915 |
-5.85% 594/952 |
| 2022 | -26.27% 538/867 |
-16.56% 335/773 |
2.70% 640/806 |
-8.72% 180/845 |
-5.74% 666/867 |
| 2021 | 53.46% 11/740 |
-9.51% 481/580 |
31.99% 48/659 |
12.06% 44/704 |
14.66% 26/740 |
| 2020 | 69.40% 147/554 |
5.67% 65/419 |
21.81% 254/466 |
11.20% 223/517 |
18.35% 145/554 |
| 2019 | 78.16% 14/410 |
21.42% 891/1146 |
1.41% 212/1228 |
17.07% 26/390 |
23.60% 5/410 |
| 2018 | - - |
- - |
- - |
-2.84% 364/1000 |
-5.56% 72/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 申万菱信智能驱动股票A VS. 东吴新产业精选股票A(580008) |